Physician
Family Medicine
Dr. David M. Wilterdink, MD
David M. Wilterdink is an expert in the field of Family Medicine. He researched medicine at Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth is ranked 37/29 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification", "Physician Practice Connections Recognition Program" and "Patient-Centered Medical Home Recognition Program". He accepts Medicare payments and is listed with Medicare.gov.
Schools
Dartmouth College
Hartford Hospital
University Conn Health Center
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amalgamated Clothing & Textile Workers Union WC
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Community Health Network
- Connecticare HMO
- Connecticare POS
- CoreSource
- First Health (Coventry Health Care) PPO
- Golden Rule
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan
- MVP Health Care
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Physician Practice Connections Recognition Program
- Patient-Centered Medical Home Recognition Program
Education
-
University of Connecticut
-
Geisel School of Medicine at Dartmouth
Drug Facts
NPI NUMBER |
|
1538144548 |
NPPES Provider LastName |
|
WILTERDINK |
NPPES Provider FirstName |
|
DAVID |
NPPES Provider ZIPCode |
|
062393509 |
NPPES Provider State |
|
CT |
Specialty Description |
|
Family Practice |
Total Claim Count |
|
9343.0 |
Distinct Opioid Count |
|
10.0 |
Opioid Claim Count |
|
366.0 |
Percent Opioid Claims |
|
3.92 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1538144548 |
Last Name Of The Provider |
WILTERDINK |
First Name Of The Provider |
DAVID |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog